STARTUP PROFILE

Neuralink

COUNTRY
USA
FOUNDED
2016
CATEGORY
Brain-Computer Interface
Developing high-channel-count implantable brain-computer interfaces to restore motor function, enable communication, and eventually merge humans with AI.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series C+
MODALITY
Intracortical
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Paralysis/motor
TARGET USER
Patients
REGULATORY STAGE
Investigational
Neuralink is the most visible high-bandwidth invasive BCI company, differentiated by its vertically integrated approach spanning surgical robotics, custom chips, and implantable threads. Its profile and capital access are unmatched, though its long-term ambitions still far exceed its current clinical scope.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
13
Neurotech wants to challenge GLP-1s
27 October – 10 November 2026

Neuralink reported first data from its VOICE speech trial. One participant with ALS reached 75 words per minute at a 5.8% word error rate in their first week, on a 125,000-word vocabulary. The early feasibility study will include six participants.

#
11
BCI reaches a new scale
30 September – 13 October 2026

Neuralink reported results from pretraining its neural decoders on more than 50,000 hours of intracortical recordings. The self-supervised approach helps decoders stay accurate despite neural signal drift, reducing recalibration for some participants from ten minutes a day to ten minutes a week. Six participants also set personal bests using their implants, including one who reached 11.32 bits per second on the Webgrid cursor task.

Articles featuring
Neuralink